ALIGNMENT HEALTHCARE, INC. (ALHC) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
31/54
2.9 / 5 stars
All 54 Win/Lose results and 66 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinALHC / S&P 35.13% / 15.20% |
WinALHC / S&P 37.21% / 15.00% |
LoseALHC / S&P -167.86% / 50.40% |
| 2026-Q11/3 |
LoseALHC / S&P -10.78% / -4.33% |
WinALHC / S&P 41.81% / 11.30% |
LoseALHC / S&P -118.75% / 27.70% |
| 2025-Q42/3 |
WinALHC / S&P 13.18% / 2.65% |
WinALHC / S&P 46.06% / 9.00% |
LoseALHC / S&P -98.53% / 13.40% |
| 2025-Q32/3 |
WinALHC / S&P 24.64% / 8.12% |
WinALHC / S&P 47.77% / 4.61% |
LoseALHC / S&P -84.42% / 13.45% |
| 2025-Q21/3 |
LoseALHC / S&P -24.81% / 10.94% |
WinALHC / S&P 50.32% / 4.83% |
LoseALHC / S&P -65.85% / 10.63% |
| 2025-Q12/3 |
WinALHC / S&P 65.51% / -4.27% |
WinALHC / S&P 50.49% / 4.98% |
LoseALHC / S&P -42.86% / 10.57% |
| 2024-Q41/3 |
LoseALHC / S&P -4.82% / 2.41% |
WinALHC / S&P 50.12% / 5.25% |
LoseALHC / S&P -13.92% / 6.15% |
| 2024-Q32/3 |
WinALHC / S&P 51.15% / 5.89% |
WinALHC / S&P 44.61% / 5.89% |
LoseALHC / S&P -10.47% / 6.11% |
| 2024-Q22/3 |
WinALHC / S&P 57.66% / 4.28% |
WinALHC / S&P 37.68% / 5.38% |
LoseALHC / S&P -7.87% / 5.12% |
| 2024-Q11/3 |
LoseALHC / S&P -42.39% / 10.56% |
WinALHC / S&P 31.14% / 5.71% |
LoseALHC / S&P 5.00% / 5.59% |
| 2023-Q42/3 |
WinALHC / S&P 24.06% / 11.69% |
WinALHC / S&P 25.80% / 6.81% |
LoseALHC / S&P -4.82% / 7.78% |
| 2023-Q33/3 |
WinALHC / S&P 20.70% / -3.27% |
WinALHC / S&P 24.28% / 7.52% |
WinALHC / S&P 10.26% / -5.03% |
| 2023-Q22/3 |
LoseALHC / S&P -9.59% / 8.74% |
WinALHC / S&P 23.71% / 9.50% |
WinALHC / S&P 8.54% / -8.57% |
| 2023-Q11/3 |
LoseALHC / S&P -45.92% / 7.50% |
WinALHC / S&P 22.14% / 10.77% |
LoseALHC / S&P -20.79% / -15.69% |
| 2022-Q41/2 |
LoseALHC / S&P -0.68% / 7.56% |
WinALHC / S&P 22.66% / 11.88% |
No dataALHC / S&P / -17.99% |
| 2022-Q32/2 |
WinALHC / S&P 3.77% / -4.88% |
WinALHC / S&P 23.30% / 13.47% |
No dataALHC / S&P / -1.41% |
| 2022-Q22/2 |
WinALHC / S&P 1.60% / -16.10% |
WinALHC / S&P 22.57% / 13.71% |
No dataALHC / S&P / 11.04% |
| 2022-Q11/2 |
LoseALHC / S&P -20.13% / -4.60% |
WinALHC / S&P 24.77% / 15.97% |
No dataALHC / S&P / 42.23% |
| 2021-Q41/2 |
LoseALHC / S&P -12.02% / 11.03% |
WinALHC / S&P 22.16% / 15.00% |
No dataALHC / S&P / 96.40% |
| 2021-Q30/1 |
LoseALHC / S&P -31.62% / 0.58% |
No dataALHC / S&P / 10.77% |
No dataALHC / S&P / 69.42% |
| 2021-Q20/1 |
LoseALHC / S&P 6.57% / 8.55% |
No dataALHC / S&P / 6.58% |
No dataALHC / S&P / 51.81% |
| 2021-Q10/0 |
No dataALHC / S&P / 6.17% |
No dataALHC / S&P / -1.06% |
No dataALHC / S&P / 7.39% |
| 2020-Q40/0 |
No dataALHC / S&P / 12.15% |
No dataALHC / S&P / -3.72% |
No dataALHC / S&P / -33.42% |
| 2020-Q30/0 |
No dataALHC / S&P / 8.93% |
No dataALHC / S&P / -2.04% |
No dataALHC / S&P / -27.10% |
| 2020-Q20/0 |
No dataALHC / S&P / 20.54% |
No dataALHC / S&P / -0.46% |
No dataALHC / S&P / -27.11% |
| 2020-Q10/0 |
No dataALHC / S&P / -19.60% |
No dataALHC / S&P / 3.47% |
No dataALHC / S&P / -14.75% |
| 2019-Q40/0 |
No dataALHC / S&P / 9.07% |
No dataALHC / S&P / 5.36% |
No dataALHC / S&P / 2.99% |
| 2019-Q30/0 |
No dataALHC / S&P / 1.70% |
No dataALHC / S&P / 5.02% |
No dataALHC / S&P / 0.21% |
| 2019-Q20/0 |
No dataALHC / S&P / 4.30% |
No dataALHC / S&P / 6.64% |
No dataALHC / S&P / 8.65% |
| 2019-Q10/0 |
No dataALHC / S&P / 13.65% |
No dataALHC / S&P / 8.12% |
No dataALHC / S&P / 14.29% |
| 2018-Q40/0 |
No dataALHC / S&P / -13.52% |
No dataALHC / S&P / 9.05% |
No dataALHC / S&P / 18.23% |
| 2018-Q30/0 |
No dataALHC / S&P / 7.71% |
No dataALHC / S&P / 10.21% |
No dataALHC / S&P / 19.06% |
| 2018-Q20/0 |
No dataALHC / S&P / 3.43% |
No dataALHC / S&P / 9.03% |
No dataALHC / S&P / 14.46% |
| 2018-Q10/0 |
No dataALHC / S&P / -0.76% |
No dataALHC / S&P / 7.68% |
No dataALHC / S&P / 12.46% |
| 2017-Q40/0 |
No dataALHC / S&P / 6.64% |
No dataALHC / S&P / 7.03% |
No dataALHC / S&P / 13.82% |
| 2017-Q30/0 |
No dataALHC / S&P / 4.48% |
No dataALHC / S&P / 5.68% |
No dataALHC / S&P / 17.57% |
| 2017-Q20/0 |
No dataALHC / S&P / 3.09% |
No dataALHC / S&P / 4.83% |
No dataALHC / S&P / 17.74% |
| 2017-Q10/0 |
No dataALHC / S&P / 6.07% |
No dataALHC / S&P / 3.67% |
No dataALHC / S&P / 13.32% |
| 2016-Q40/0 |
No dataALHC / S&P / 3.82% |
No dataALHC / S&P / 2.09% |
No dataALHC / S&P / 7.05% |
| 2016-Q30/0 |
No dataALHC / S&P / 3.85% |
No dataALHC / S&P / 0.20% |
No dataALHC / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ALHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -17.11% | 20.78% |
| Annualized return | -17.11% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ALHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -25.41% | 83.14% |
| Annualized return | -5.70% | 12.86% |
10Y · 2021-03-26 to 2026-08-27
| Metric | ALHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -21.66% | 319.30% |
| Annualized return | -2.41% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |